TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32192592

Group type: EXPERIMENTAL
Intervention: Physical activity (first tertile, median = 7.7 MET hours/week)
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Physical activity (second tertile, median = 27.8 MET hours/week)
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Physical activity (third tertile, median = 95.7 MET hours/week)
Number of subjects: 785

Group type: COMPARATOR
Intervention: No physical activity relation
Number of subjects: 785
Study: 36197359

Group type: EXPERIMENTAL
Intervention: Multicomponent training
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Combined training
Number of subjects: 2
Study: 32936981

Group type: EXPERIMENTAL
Intervention: Culturally targeted educational booklet about genetic counseling/genetic testing (GC/GT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Fact sheet about breast cancer survivorship (control)
Number of subjects: 52
Study: 32681726

Group type: EXPERIMENTAL
Intervention: Artificial cycle FET
Number of subjects: 9267

Group type: COMPARATOR
Intervention: Stimulated cycle FET
Number of subjects: 9267

Group type: COMPARATOR
Intervention: Natural cycle FET
Number of subjects: 9267
Study: 35294860

Group type: EXPERIMENTAL
Intervention: Focal psychodynamic therapy
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Enhanced cognitive behaviour therapy
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Optimised treatment as usual
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Global outcome
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: BMI predictors
Number of subjects: 242
Study: 32306797

Group type: EXPERIMENTAL
Intervention: Triple therapy: aspirin+prasugrel/ticagrelor+vorapaxar
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Dual therapy (drop aspirin): prasugrel/ticagrelor+vorapaxar
Number of subjects: 130

Group type: COMPARATOR
Intervention: DAPT: aspirin+prasugrel/ticagrelor
Number of subjects: 130
Study: 34354017

Group type: EXPERIMENTAL
Intervention: Pain neuroscience education (PNE) training
Number of subjects: 319

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 319
Study: 34478926

Group type: EXPERIMENTAL
Intervention: Atosiban (6.75 mg IV 30 min before embryo transfer, followed by 18 mg/h for 1 h, then 6 mg/h for 2 h)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Atosiban
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Atosiban (in women >35 years)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (in women >35 years)
Number of subjects: 50
Study: 35085999

Group type: EXPERIMENTAL
Intervention: Real dry needling (DN)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham dry needling
Number of subjects: 50
Study: 33938088

Group type: EXPERIMENTAL
Intervention: PFO closure plus antiplatelet therapy
Number of subjects: 145

Group type: COMPARATOR
Intervention: Antiplatelet therapy alone
Number of subjects: 145
Study: 32870042

Group type: EXPERIMENTAL
Intervention: Autologous Protein Solution (APS) injection
Number of subjects: 46

Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 46
Study: 36040742

Group type: EXPERIMENTAL
Intervention: Exercise intervention (minimum of 3 supervised 90-minute sessions per week for 20 weeks)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 109
Study: 33184453

Group type: EXPERIMENTAL
Intervention: Iodine status (measured as urinary iodine concentration - UIC)
Number of subjects: 954

Group type: EXPERIMENTAL
Intervention: Iodine status (UI/Cr <150 µg/g)
Number of subjects: 954
Study: 34478596

Group type: EXPERIMENTAL
Intervention: Simulation-based training (in situ simulation training)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulation experience
Number of subjects: 0
Study: 32088370

Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell transplantation (HSCT) in GATA2 cohort
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control A (patients without germline GATA2 mutations and BMF/MDS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control B (patients without germline GATA2 mutations and acute leukemia)
Number of subjects: 0
Study: 34152238

Group type: EXPERIMENTAL
Intervention: mHealth management with an implantable glucose sensor and a mobile application
Number of subjects: 68

Group type: COMPARATOR
Intervention: Usual health management
Number of subjects: 68
Study: 33582258

Group type: EXPERIMENTAL
Intervention: Laryngeal Tube (LT)
Number of subjects: 1996

Group type: COMPARATOR
Intervention: Endotracheal Intubation (ETI)
Number of subjects: 1996
Study: 35551053

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) using a low-level GaAlAs diode laser (continuous wave of 810 nm wavelength, power of 200 mW, energy density of 12–14 J/cm2) for 12 sessions (2 times/week for 6 weeks)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (laser probe turned off)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 26
Study: 33637567

Group type: EXPERIMENTAL
Intervention: Structured education programme (n=145)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Usual care (n=146)
Number of subjects: 291
Study: 32343625

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33214537

Group type: EXPERIMENTAL
Intervention: Mindfulness-based weight loss intervention
Number of subjects: 194

Group type: COMPARATOR
Intervention: Active-control with identical diet-exercise guidelines
Number of subjects: 194
Study: 32022725

Group type: EXPERIMENTAL
Intervention: CPPopt (optimal cerebral perfusion)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ABPopt (arterial pressures)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blood pressure regulation above the lower limit of autoregulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targeted control of brain and systemic blood pressures
Number of subjects: 0
Study: 33641621

Group type: EXPERIMENTAL
Intervention: Protect Your Family intervention administered by lay healthcare workers
Number of subjects: 1399

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1399
Study: 32939989

Group type: EXPERIMENTAL
Intervention: EIP/GBR
Number of subjects: 38

Group type: COMPARATOR
Intervention: ARP/CTG
Number of subjects: 38
Study: 32380509

Group type: EXPERIMENTAL
Intervention: Acid-suppressive therapy + feeding bundle
Number of subjects: 76

Group type: COMPARATOR
Intervention: Acid-suppressive therapy only (conventional)
Number of subjects: 76
Study: 32291466

Group type: EXPERIMENTAL
Intervention: Obesity (BMI ≥ 30 kg/m2)
Number of subjects: 4729

Group type: EXPERIMENTAL
Intervention: High genetic risk (GRS quintile 5)
Number of subjects: 4729

Group type: EXPERIMENTAL
Intervention: Unfavourable lifestyle
Number of subjects: 4729

Group type: EXPERIMENTAL
Intervention: Low GRS and favourable lifestyle with obesity
Number of subjects: 4729
Study: 35443618

Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) algorithm using lateral cervical spine radiographs
Number of subjects: 207
Study: 32525410

Group type: EXPERIMENTAL
Intervention: OCT-guided BVS implantation
Number of subjects: 176

Group type: COMPARATOR
Intervention: Angiography-guided BVS implantation
Number of subjects: 176

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 176
Study: 36179986

Group type: EXPERIMENTAL
Intervention: Omidubicel
Number of subjects: 108

Group type: COMPARATOR
Intervention: Standard UCB
Number of subjects: 108
Study: 33064895

Group type: EXPERIMENTAL
Intervention: New metformin users with depression
Number of subjects: 165056

Group type: COMPARATOR
Intervention: New metformin users without depression (controls)
Number of subjects: 165056

Group type: EXPERIMENTAL
Intervention: Trajectories of adherence
Number of subjects: 165056
Study: 32971492

Group type: EXPERIMENTAL
Intervention: Isokinetic eccentric training protocols at 45°/s, 120°/s, 210°/s, and 300°/s
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (n = 14)
Number of subjects: 47
Study: 37732853

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 49

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 49
Study: 35732505

Group type: EXPERIMENTAL
Intervention: True Acupuncture (TA) group, 20 sessions over 8 weeks, each session lasting 30 minutes, achieving deqi sensation.
Number of subjects: 218

Group type: COMPARATOR
Intervention: Superficial Acupuncture (SA) group, same sessions and treatment frequency as TA, avoiding deqi sensation.
Number of subjects: 218
Study: 33268427

Group type: EXPERIMENTAL
Intervention: Logistic regression with various missing data imputation methods
Number of subjects: 355823

Group type: EXPERIMENTAL
Intervention: Random forest
Number of subjects: 355823

Group type: EXPERIMENTAL
Intervention: Neural networks
Number of subjects: 355823

Group type: EXPERIMENTAL
Intervention: Case-wise deletion for missing data
Number of subjects: 355823

Group type: EXPERIMENTAL
Intervention: Mean value imputation, random forest, extremely randomised trees (extra-trees regression), ridge regression, normal value imputation
Number of subjects: 355823
Study: 36195963

Group type: EXPERIMENTAL
Intervention: MyComrade intervention
Number of subjects: 121
Study: 33127571

Group type: EXPERIMENTAL
Intervention: Endovascular coiling (specific type not mentioned, but includes bare platinum coils and hydrogel coils)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Endovascular coiling (specific type not mentioned)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Literature review on QOL in patients with UIAs
Number of subjects: 270
Study: 36418118

Group type: EXPERIMENTAL
Intervention: Financial incentive of €20
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Mailing back the HPV self-sampling kit (HPVss)
Number of subjects: 10000
Study: 34559691

Group type: EXPERIMENTAL
Intervention: Gentle, massage-like head stroking for 60 minutes
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (resting without massage)
Number of subjects: 14
Study: 36442467

Group type: EXPERIMENTAL
Intervention: Early feeding group (1 day of trophic feeding at 20-24 mL/kg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Late feeding group (4 days of trophic feeding at 20-24 mL/kg/day)
Number of subjects: 60
Study: 33632144

Group type: EXPERIMENTAL
Intervention: Azithromycin (part of the BREATHE trial)
Number of subjects: 410
Study: 35966238

Group type: EXPERIMENTAL
Intervention: Childlike concept with refined nursing intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Refined nursing care
Number of subjects: 100
Study: 33526496

Group type: EXPERIMENTAL
Intervention: Describing side effects as a sign treatment is working
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard empathetic message about side effects
Number of subjects: 0
Study: 35315017

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers (nifedipine, nicardipine)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (healthy pregnant women, n=65)
Number of subjects: 65
Study: 32147352

Group type: EXPERIMENTAL
Intervention: Serum PSA-based screening
Number of subjects: 4276

Group type: COMPARATOR
Intervention: Follow-up without intervention
Number of subjects: 4276
Study: 34476447

Group type: EXPERIMENTAL
Intervention: Continuous oral health education after treatments
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clinical education at the time of treatments
Number of subjects: 60
Study: 32044268

Group type: EXPERIMENTAL
Intervention: Microwave Ablation (MWA)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Radiofrequency Ablation (RFA)
Number of subjects: 93
Study: 35468646

Group type: EXPERIMENTAL
Intervention: Endo-TLIF
Number of subjects: 46

Group type: COMPARATOR
Intervention: Open-TLIF
Number of subjects: 46
Study: 34604400

Group type: EXPERIMENTAL
Intervention: Spiritual counseling (8 sessions of 60 minutes each)
Number of subjects: 50
Study: 33312712

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT), low-energy intervention group, treated once a week for 10 weeks.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo control group, treated once a week for 10 weeks.
Number of subjects: 40
Study: 35906106

Group type: EXPERIMENTAL
Intervention: PVRV‐NG
Number of subjects: 342

Group type: COMPARATOR
Intervention: HDCV
Number of subjects: 342
Study: 32752306

Group type: EXPERIMENTAL
Intervention: Thermotherapy plus neck stabilization exercise
Number of subjects: 35

Group type: COMPARATOR
Intervention: Neck stabilization exercise alone
Number of subjects: 35
Study: 36244813

Group type: EXPERIMENTAL
Intervention: Fluorescence group (near-infrared autofluorescence and indocyanine green fluorescence)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluorescence group
Number of subjects: 0
Study: 34411059

Group type: EXPERIMENTAL
Intervention: Intraoperative dexmedetomidine use
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Frontal location of tumor
Number of subjects: 562

Group type: COMPARATOR
Intervention: Awake craniotomy
Number of subjects: 562
Study: 32340878

Group type: EXPERIMENTAL
Intervention: Computer simulation group (using data from duplex ultrasonography for model simulations)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Control group (standard work up without simulation)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Immediate post-operative flow prediction
Number of subjects: 236
Study: 36115774

Group type: EXPERIMENTAL
Intervention: Manual segmentation
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Automated segmentation
Number of subjects: 391

Group type: COMPARATOR
Intervention: Radiologist assessment
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Combined model of manually segmented radiomics signature and radiologist assessment
Number of subjects: 391
Study: 34886168

Group type: EXPERIMENTAL
Intervention: CR + IMT
Number of subjects: 90

Group type: COMPARATOR
Intervention: CR
Number of subjects: 90

Group type: COMPARATOR
Intervention: IMT
Number of subjects: 90
Study: 32690105

Group type: EXPERIMENTAL
Intervention: NEON Intervention (treatment as usual plus immediate access to the NEON Intervention for 1 year)
Number of subjects: 883

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis using EQ‐5D‐5 L and Client Service Receipt Inventory data
Number of subjects: 883

Group type: COMPARATOR
Intervention: Treatment as usual plus access to the NEON Intervention after 1 year
Number of subjects: 883
Study: 35985418

Group type: EXPERIMENTAL
Intervention: 12-month home-based physical exercise (supervised by physiotherapist, 60 minutes, twice a week)
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: 12-month home-based physical exercise
Number of subjects: 299

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 299
Study: 34938893

Group type: EXPERIMENTAL
Intervention: Oral magnesium oxide (MgOx)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Oral magnesium citrate (MgCit)
Number of subjects: 15
Study: 36443737

Group type: EXPERIMENTAL
Intervention: TURNing InTervention (TURN‐IT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 60
Study: 34128480

Group type: EXPERIMENTAL
Intervention: Endo.Adm feedback
Number of subjects: 16

Group type: COMPARATOR
Intervention: No feedback (control group)
Number of subjects: 16
Study: 35181385

Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP) nasal spray
Number of subjects: 84

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 84
Study: 34314511

Group type: EXPERIMENTAL
Intervention: PCV13 (13-valent pneumococcal conjugate vaccines)
Number of subjects: 9748

Group type: EXPERIMENTAL
Intervention: Diphtheria toxoid and tetanus toxoid vaccine
Number of subjects: 9748

Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine
Number of subjects: 9748

Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine (PPSV23)
Number of subjects: 9748

Group type: EXPERIMENTAL
Intervention: Flaxseed extract
Number of subjects: 9748

Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol
Number of subjects: 9748

Group type: EXPERIMENTAL
Intervention: Estradiol
Number of subjects: 9748

Group type: EXPERIMENTAL
Intervention: Turmeric extract
Number of subjects: 9748

Group type: EXPERIMENTAL
Intervention: Ubidecarenone
Number of subjects: 9748

Group type: EXPERIMENTAL
Intervention: Azelastine
Number of subjects: 9748

Group type: EXPERIMENTAL
Intervention: Pseudoephedrine
Number of subjects: 9748

Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Number of subjects: 9748

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 9748

Group type: EXPERIMENTAL
Intervention: Fluticasone
Number of subjects: 9748

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 9748
Study: 32759229

Group type: EXPERIMENTAL
Intervention: Synbiotic supplement
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32302791

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (MM)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Activation skills (AS)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 300
Study: 33499887

Group type: EXPERIMENTAL
Intervention: Prednisone 40 mg days 1 to 4, then 20 mg days 5 to 8
Number of subjects: 184

Group type: COMPARATOR
Intervention: Usual care defined by the attending physician
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Prednisone treatment
Number of subjects: 184
Study: 32971040

Group type: EXPERIMENTAL
Intervention: semaglutide 0.5 mg
Number of subjects: 8416

Group type: EXPERIMENTAL
Intervention: semaglutide 1.0 mg
Number of subjects: 8416
Study: 35711417

Group type: EXPERIMENTAL
Intervention: High-risk group (based on prognostic model of eight PCD-related lncRNAs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-risk group (based on prognostic model of eight PCD-related lncRNAs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cluster 2 (identified through cluster analysis)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: lncRNA U62317.4 (studied in vitro and in vivo)
Number of subjects: 0
Study: 34174448

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 32891139

Group type: EXPERIMENTAL
Intervention: Weekly vitamin D2 50,000 IU
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Weekly vitamin D2 2500 IU
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 36335344

Group type: EXPERIMENTAL
Intervention: Misoprostol provided by midwives
Number of subjects: 1140

Group type: COMPARATOR
Intervention: Misoprostol provided by physicians
Number of subjects: 1140
Study: 32816890

Group type: EXPERIMENTAL
Intervention: Axitinib (5 mg twice daily) and Pembrolizumab (2 mg/kg every 3 weeks)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Axitinib and Pembrolizumab
Number of subjects: 52
Study: 36225761

Group type: EXPERIMENTAL
Intervention: Calorie monitoring (Standard)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Red food monitoring (Simplified)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 72
Study: 35140341

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 1178

Group type: EXPERIMENTAL
Intervention: Hypoxic gene signatures
Number of subjects: 1178
Study: 34758759

Group type: EXPERIMENTAL
Intervention: Psychomotor intervention program (EG1)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Combined exercise program (psychomotor intervention + whole-body vibration program) (EG2)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (usual daily activities)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both experimental groups (EG1 and EG2)
Number of subjects: 51
Study: 35761363

Group type: EXPERIMENTAL
Intervention: PEP4PA intervention (multilevel, peer-led program including self-monitoring, health coaching, group walks, social support, community advocacy)
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: PEP4PA intervention
Number of subjects: 476

Group type: COMPARATOR
Intervention: Control group (usual programming)
Number of subjects: 476

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 476
Study: 36099141

Group type: EXPERIMENTAL
Intervention: ANS 0 (39 patients)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: ANS 1 (51 patients)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: ANS 2 (33 patients)
Number of subjects: 123

Group type: COMPARATOR
Intervention: ANS 0
Number of subjects: 123

Group type: COMPARATOR
Intervention: ANS 1
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: ANS 2
Number of subjects: 123
Study: 32569429

Group type: EXPERIMENTAL
Intervention: Topical 0.1% capsaicin cream
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 30
Study: 36394475

Group type: EXPERIMENTAL
Intervention: Regular low-dose sustained-release morphine (0/8/16/24 mg every 24 hours)
Number of subjects: 20
Study: 34187862

Group type: COMPARATOR
Intervention: Home medication
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Nonhome medication
Number of subjects: 462
Study: 32420825

Group type: EXPERIMENTAL
Intervention: Group social work intervention (8 sessions)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 58
Study: 35658908

Group type: EXPERIMENTAL
Intervention: Deep Learning Image Reconstruction (DLIR) - High intensity (H)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Deep Learning Image Reconstruction (DLIR) - Medium intensity (M)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Deep Learning Image Reconstruction (DLIR) - Low intensity (L)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Adaptive Statistical Iterative Reconstruction V (ASiR-V) - 50%
Number of subjects: 25

Group type: COMPARATOR
Intervention: Adaptive Statistical Iterative Reconstruction V (ASiR-V) - 30%
Number of subjects: 25

Group type: COMPARATOR
Intervention: Filtered Back Projection (FBP)
Number of subjects: 25
Study: 33630199

Group type: EXPERIMENTAL
Intervention: Stronger Together intervention (a three‐session dyadic intervention involving HIV testing and adherence counseling)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Standard of Care (SOC) control arm
Number of subjects: 318
Study: 32885419

Group type: EXPERIMENTAL
Intervention: Okara soup (4.1 g fiber/meal)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (soymilk, 0.1 g fiber/meal)
Number of subjects: 52